UBS Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.5M | Buy |
|
|||||
|
2025
Q2 | $708K | Sell |
|
|||||
|
2025
Q1 | $5.23M | Buy |
|
|||||
|
2024
Q4 | $4.15M | Buy |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $447K | Sell |
|
|||||
|
2024
Q1 | $863K | Buy |
|
|||||
|
2023
Q4 | $89.4K | Sell |
|
|||||
|
2023
Q3 | $76.7K | Sell |
|
|||||
|
2023
Q2 | $112K | Buy |
|
|||||
|
2023
Q1 | $81.8K | Sell |
|
|||||
|
2022
Q4 | $374K | Buy |
|
|||||
|
2022
Q3 | $278K | Sell |
|
|||||
|
2022
Q2 | $265K | Sell |
|
|||||
|
2022
Q1 | $251K | Sell |
|
|||||
|
2021
Q4 | $323K | Sell |
|
|||||
|
2021
Q3 | $519K | Buy |
|
|||||
|
2021
Q2 | $469K | Buy |
|
|||||
|
2021
Q1 | $497K | Buy |
|